2002 Quarterly Earnings Reports
Combichem and Services Sector Companies
Updated 4/22/03
Current publicly reported financial results (in $millions) for combinatorial chemistry-based companies. Please note that all figures may reflect non-recurring charges, credits, gains or losses. Company fiscal years may not run according to the calendar year. Earnings will be updated as Network Science receives the data.
| Q1 | Q2 | Q3 | Q4 | YTD | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | |
| Albany Molecular (ARMI) | $27.4 | $8.8 | $31.8 | $10.6 | $32.1 | $10.2 | $31.5 | $11.0 | $122.8 | $40.6 |
| Arena Pharmaceuticals (ARNA) | $4.2 | ($6.5) | $5.8 | ($7.3) | $3.0 | ($10.3) | $6.4 | ($8.8) | $19.4 | ($32.9) |
| Argonaut Technologies (AGNT) | $4.8 | ($3.1) | $6.7 | ($3.2) | $7.8 | ($5.3) | $7.6 | ($2.2) | $26.9 | ($13.8) |
| ArQule, Inc. (ARQL) | $14.0 | ($8.4) | $16.2 | ($4.9) | $16.5 | ($5.5) | $16.2 | ($59.1) | $62.9 | ($77.9) |
| CompuGen (CGEN) | $2.8 | ($3.2) | $2.8 | ($2.8) | $2.8 | ($3.0) | $2.7 | ($0.3) | $11.1 | ($12.2) |
| Lion Bioscience (LEON), in Euros | 10.9 | (23.4) | 7.5 | (19.2) | 5.2 | (92.7) | 23.6 | (135.3) | ||
| Orchid Bioscience (ORCH) | $15.8 | ($10.5) | $16.4 | ($12.2) | $17.0 | ($22.3) | $13.0 | ($35.1) | $50.4 | ($80.1) |
| Pharmacopeia (PCOP) | $26.8 | ($6.0) | $29.3 | ($5.1) | $30.9 | ($6.3) | $37.4 | $5.8 | $124.4 | ($11.6) |
| Repligen (RGEN) | $1.5 | $0.9 | $1.6 | ($1.0) | $1.7 | ($1.1) | $2.4 | ($0.8) | $7.2 | ($1.9) |
| 3D Pharmaceuticals (DDDP) | $6.2 | ($8.8) | $6.5 | ($7.2) | $5.5 | ($7.7) | $6.3 | ($6.1) | $24.5 | ($29.8) |
| Tripos, Inc. (TRPS) | $12.7 | $1.6 | $11.1 | ($1.3) | $11.1 | ($0.8) | $16.2 | $1.4 | $51.1 | $0.9 |
| Totals for Results in USD | $116.2 | ($35.2) | $128.2 | ($34.4) | $128.4 | ($52.1) | $139.7 | ($94.2) | $500.7 | ($218.7) |
